CANF · Can-Fite BioPharma Ltd. · Documents
Market Cap
$5.73M
Shares
3.03M
Volume · Oct 21
11.17K
Avg daily vol (3M)
358.4K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2021-04-23 | — | |
| 6-K | — | 2021-04-22 | — | |
| 6-K | — | 2021-04-20 | — | |
| 6-K | — | 2021-04-05 | — | |
| 6-K | — | 2021-03-30 | — | |
| 20-F | — | 2021-03-25 | 2020-12-31 | |
| 6-K | — | 2021-03-25 | — | |
| 6-K | — | 2021-03-18 | — | |
| 6-K | — | 2021-03-16 | — | |
| 6-K | — | 2021-03-05 | — | |
| 6-K | — | 2021-02-22 | — | |
| 6-K | — | 2021-02-01 | — | |
| 6-K | — | 2021-01-28 | — | |
| 6-K | — | 2021-01-08 | — | |
| 6-K | — | 2020-12-15 | — | |
| 6-K | — | 2020-12-14 | — | |
| 6-K | — | 2020-12-09 | — | |
| 6-K | — | 2020-12-02 | — | |
| 6-K | — | 2020-11-30 | — | |
| 6-K | — | 2020-11-24 | — | |
| 6-K | — | 2020-11-16 | — | |
| 6-K | — | 2020-10-28 | — | |
| 6-K | — | 2020-10-13 | — | |
| 6-K | — | 2020-10-06 | — | |
| 6-K | — | 2020-09-30 | — | |
| 6-K | — | 2020-08-31 | — | |
| 6-K | — | 2020-08-27 | 2020-06-30 | |
| 6-K | — | 2020-08-25 | — | |
| 6-K | — | 2020-08-12 | — | |
| 6-K | — | 2020-08-05 | — | |
| 6-K | — | 2020-07-27 | — | |
| 6-K | — | 2020-07-20 | — | |
| 6-K | — | 2020-07-15 | — | |
| 6-K | — | 2020-07-08 | — | |
| 6-K | — | 2020-07-06 | — | |
| 6-K | — | 2020-06-30 | — | |
| 6-K | — | 2020-06-29 | — | |
| 6-K | — | 2020-06-12 | — | |
| 6-K | — | 2020-06-10 | — | |
| 6-K | — | 2020-06-09 | — | |
| 6-K | — | 2020-06-04 | — | |
| 6-K | — | 2020-06-01 | 2019-12-31 | |
| 6-K | — | 2020-05-21 | — | |
| 6-K | — | 2020-05-18 | — | |
| 6-K | — | 2020-05-15 | — | |
| 6-K | — | 2020-04-28 | — | |
| 6-K | — | 2020-04-27 | — | |
| 6-K | — | 2020-04-21 | — | |
| 6-K | — | 2020-04-13 | — | |
| 6-K | — | 2020-04-07 | — |
Showing 201–250 of 279 filings